home / stock / adct / adct articles

ADCT Articles, ADC Therapeutics SA - From 03/06/24

Stock Information
Company Name: ADC Therapeutics SA
Stock Symbol: ADCT
Market: NYSE
Website: adctherapeutics.com
Menu
ADCT ADCT Quote ADCT Short ADCT News ADCT Articles ADCT Message Board
Get ADCT Alerts

News, Short Squeeze, Breakout and More Instantly...
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit | Benzinga

LAUSANNE, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE:ADCT) announced today that Ameet Mallik, Chief Executive Off...
ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024 | Benzinga

LAUSANNE, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE:ADCT) today announced that it will host a conference call an...

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting | Benzinga

Preclinical data support future clinical development of ADCs targeting Claudin-6 and NaPi2b Additional presentations include clinical and indepen...

ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference | Benzinga

LAUSANNE, Switzerland, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE:ADCT) announced today that Ameet Mallik, Chief Executive Offi...
Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Myricx Bio Appoints Dr Chris Martin, Biotech Entrepreneur and ADC Pioneer, as Chairman of its Board of Directors | Benzinga

LONDON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx'), a UK biotech company focused on the discovery and development of a compl...

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The com...
ADC Therapeutics Announces Abstracts Accepted for Presentation at the 65th ASH Annual Meeting | Benzinga

Presentations to highlight clinical utility of ZYNLONTA® (loncastuximab tesirine-lpyl) as a single agent and in combination Oral presentation...

Myricx Expands its ADC Expertise with the Appointment of Francesca Zammarchi as CSO | Benzinga

LONDON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx'), a UK biotech company focusing on the discovery and development of a comp...

ADC Therapeutics to Participate in September Investor Conferences | Benzinga

LAUSANNE, Switzerland, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE:ADCT) today announced that Ameet Mallik, Chief Executive Off...
Previous 10 Next 10